Study of Apelin Serum Levels in patients with Hepatitis C virus Chronic Liver Disease.
DOI:
https://doi.org/10.24297/jab.v7i2.4564Keywords:
apelin, insulin resistance, liver fibrosis, steatosis and hepatitis C virus (HCV).Abstract
Objective: The aim was to study the apelin serum levels and assessment of insulin resistance role in chronic liver diseased patients.
Background: Apelin is involved in many physiological and pathological function in human, it is thought to increase liver fibrosis progression with the aid of insulin resistance. There is a significant association of insulin resistance and apelin level and liver progression.
Materials and methods: This study was carried at Internal Medicine Department and National Liver Institute, Menoufia University Hospitals, from the period of January 2014 to October 2014. Subjects were classified into 5 groups each group contained 15 subjects: Group (I) served as healthy control of matched sex and age, Group (II) had liver steatosis without HCV infection, Group (III) had HCV-related liver steatosis, Group (IV) had HCV-related liver fibrosis and Group (V) had HCV-related liver cirrhosis.
Results: Serum apelin level was elevated in liver steatosis, fibrosis and it was significantly higher in cirrhotic patients. Insulin resistance correlate positively with serum apelin and liver disease progression.
Conclusion: Serum apelin is significantly higher in patients with HCV-liver cirrhosis compared to HCV-related liver fibrosis and steatosis that say, apelin plays a role in progression of liver disease and inhibition of the apelinergic system could offer new therapeutic opportunities against liver complication. A strong relation between insulin resistance and apelin on one side and other side between insulin resistance and liver fibrosis progression.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
All articles published in Journal of Advances in Linguistics are licensed under a Creative Commons Attribution 4.0 International License.